Y. Brewer

发表

Concurrent cisplatin, etoposide, and radiotherapy for unresectable stage III nonsmall cell lung cancer: a phase II study.

B. Chauvet, F. Reboul, C. Faure, 1996, International journal of radiation oncology, biology, physics.

High dose rate endobronchial brachytherapy: results and complications in 189 patients.

B. Chauvet, F. Reboul, R. Garcia, 1998, The European respiratory journal.

EFFECT OF GRAFT PERFUSION WITH TWO CD45 MONOCLONAL ANTIBODIES ON INCIDENCE OF KIDNEY ALLOGRAFT REJECTION

M. Bewick, G. Hale, H. Waldmann, 1989, The Lancet.

0 Phase ILlI Clinical Trials CONCURRENT CISPLATIN, ETOPOSIDE, AND RADIOTHERAPY FOR -ECTARLE STAGE III NONSMALL CELL LUNG CANCER: A PHASE II STUDY

B. Chauvet, Y. Brewer, O. Reboul, 1996 .

Direct Treatment Costs for Patients with Lung Cancer from First Recurrence to Death in France

I. Durand-zaleski, J. Trédaniel, P. Piedbois, 2012, PharmacoEconomics.

Radiation therapy with concomitant continuous infusion cisplatin for unresectable nonsmall cell lung carcinoma.

D. Shrieve, B. Chauvet, F. Reboul, 1994, International journal of radiation oncology, biology, physics.

Prevention of renal allograft rejection by perfusion with antileukocyte common monoclonal antibodies is dependent on good uptake of antibody by interstitial dendritic cells.

M. Bewick, K. Welsh, D. Taube, 1989, Transplantation proceedings.

Outpatient treatment with subcutaneous interleukin-2 and interferon alfa administration in combination with fluorouracil in patients with metastatic renal cell carcinoma: results of a sequential nonrandomized phase II study. Subcutaneous Administration Propeukin Program Cooperative Group.

C. Chastang, A. Monnier, Y. Chrétien, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.

B. Chauvet, J. Fijuth, F. Reboul, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.

B. Chauvet, F. Reboul, J. Davin, 1996, The Journal of urology.

Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program

L. Zelek, M. Namer, J. Pierga, 2004, Breast Cancer Research and Treatment.

Combined radiation therapy and cisplatin for locally advanced carcinoma of the urinary bladder

B. Chauvet, F. Reboul, J. Davin, 1993, Cancer.